AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06092554 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will receive two capsules, twice daily for 30 days, one through the nasogastric tube and one spread on the oropharynx. The placebo capsules contain a powdered glucose polymer that is unharmful for the patient and will be provided by the sponsor. The placebo capsules look identical to the probiotic capsules; the powder will be similar when opened. The capsule for nasogastric tube will be opened and suspended in 100 ml of tap water. The capsule for the oropharynx will be opened and suspended in sterile water based surgical lubricant. The administration must happen at least 30 minutes after oral antiseptic product usage (e.g. daily chlorhexidine oral care), which otherwise might neutralize the study supplement's action.
Study NCT05688878 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Threshold electrical stimulation
Description: Threshold stimulation (EDS) is based on low-intensity (\<100 Hz) and long-duration current and is applied with superficial electrodes. Threshold stimulation provides a natural proprioception by depolarizing the sensory and motor nerves without causing any muscle contraction.This treatment will be applied for 4 weeks, 3 days a week, for 1 hour.
Study NCT06194513 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention 1: Twice a day for 1 week PIOMI
Description: Preterm babies will receive two sessions of treatment every day for a week, for a total of 14 sessions. Each session will be five minutes. The application is done at a time when the baby is peaceful and not very hungry. When the application is performed, the baby is positioned on his back and in a way that feels comfortable.
Study NCT06194513 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention 2: Once a day for 2 weeks PIOMI
Description: Preterm babies will receive a total of 14 sessions of treatment, one every day for two weeks. Each session will be five minutes. The application is done at a time when the baby is peaceful and not very hungry. When the application is performed, the baby is positioned on his back and in a way that feels comfortable.
Study NCT04756505 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bintrafusp Alfa
Description: Given IV
Study NCT04756505 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Immunocytokine NHS-IL12
Description: Given SC
Study NCT04756505 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Undergo radiation therapy
Study NCT04754360 — intervention group
Intervention type: OTHER
Intervention: Evaluation of functional impairment
Description: Symptom burden and functional impairment will be evaluated with EHRA Score, 6-min walk test and 30-second sit-to-stand test
Study NCT04754360 — intervention group
Intervention type: OTHER
Intervention: Evaluation of pulmonary function
Description: Pulmonary function will be evaluated using basic spirometry and respiratory pressure meter.
Study NCT04754360 — intervention group
Intervention type: OTHER
Intervention: Evaluation of quality of life
Description: Quality of life will be evaluated using Short Form-36 Questionnaire.
Study NCT04754360 — intervention group
Intervention type: OTHER
Intervention: Evaluation of physical activity level
Description: Physical activity level will be evaluated using International Physical Activity Questionnaire Short Form
Study NCT05352126 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Biocide
Description: The product being researched, which is a biocide solution in a spray for atmospheric use without a propellant, will be sprayed in the bedroom of each patient at a rate of 2 sprays per day in the evening (half an hour before going to bed).
Study NCT05352126 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biocide
Description: The product being researched, which is a biocide solution in a spray for atmospheric use without a propellant, will be sprayed in the bedroom of each patient at a rate of 2 sprays per day in the evening (half an hour before going to bed).
Study NCT05123833 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hypospadias repair
Description: surgical repair of hypospadias
Study NCT04973475 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indocyanine Green
Description: Laparoscopic distal gastrectomy with lymph node dissection for early gastric cancer using Indocyanine Green Tracer
Study NCT05533138 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Therapist Guided Internet-CBT for antenatal depression
Description: A 10 week long, structured self-help program with weekly reports to, and feedback from, a CBT therapist over the Internet. Includes traditional CBT-methods for depression adapted for antenatal depression.
Study NCT05533138 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapist Guided Internet-CBT for antenatal depression and perinatal extra support.
Description: A 10 week long, structured self-help program with weekly reports to, and feedback from, a CBT therapist over the Internet. Includes traditional CBT-methods for depression adapted for antenatal depression. Additionally, up to three supportive contacts with a midwife or perinatal mental health nurse to support ICBT treatment and adress general pregnancy related health problems.
Study NCT05533138 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diagnostic assessment by telephone, video or face-to face - Allocation by chance
Description: Structured diagnostic perinatal psychiatric assessment of women screening positive for antenatal depression (pregnancy week 8-29) by telephone, video or in a face-to-face meeting. Assessment form allocation by chance.
Study NCT05533138 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diagnostic assessment by telephone, video or face-to face - Allocation by chance
Description: Structured diagnostic perinatal psychiatric assessment of women screening positive for antenatal depression (pregnancy week 8-29) by telephone, video or in a face-to-face meeting. Assessment form allocation by chance.
Study NCT05533138 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diagnostic assessment by telephone, video or face-to face - Allocation by choice
Description: Structured diagnostic perinatal psychiatric assessment of women screening positive for antenatal depression (pregnancy week 8-29) by telephone, video or in a face-to-face meeting. Assessment form allocation based on patient preference.
Study NCT05533138 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diagnostic assessment by telephone, video or face-to face - Allocation by choice
Description: Structured diagnostic perinatal psychiatric assessment of women screening positive for antenatal depression (pregnancy week 8-29) by telephone, video or in a face-to-face meeting. Assessment form allocation based on patient preference.
Study NCT04808570 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQ-B3525 tablets
Description: TQ-B3525 tablet administered 20mg orally, once daily in 28-day cycle.
Study NCT06097000 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: powered exoskeletons
Description: Whether to use powered exoskeletons for exercise rehabilitation
Study NCT05813600 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nirmatrelvir/Ritonavir
Description: Patients in both groups were given Lianhua Qingwen Capsule orally, 3 times/day, 6 g/time. oral antipyretic (ibuprofen suspension 10ml) and symptomatic supportive treatment for body temperature >38.5 ℃. The study group was given Nirmatrelvir 300mg/Ritonavir 100mg orally, q12h, for 5 days, and the control group not given any antiviral drugs.
Study NCT06538948 — intervention group
Intervention type: PROCEDURE
Intervention: Bariatric Surgery
Description: The intervention is not assigned to the participant after recruitment in the study, rather the intervention is an inclusion criteria for participation in the study.
Study NCT04896554 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health literacy scale
Description: The Turkish version of The European Health Literacy Survey (HLS-EU) Health Literacy Questionnaire scale (ASOY-TR) was used to measure health literacy. This scale consists of 47 questions. Each item has 4 degrees such that 1 = Very difficult, 2 = Difficult, 3 = Easy, 4 = Very easy. Code 5 is used for the expression I don't know. The total score that can be obtained from the scale is between 47-188. For the sake of ease of calculation, the total score is standardized with the following formula to take a value between 0-50.~Formula = Index = (arithmetic mean-1) x \[50/3\] High score means better health literacy.
Study NCT03924752 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Powered hip exoskeleton
Description: The study team will test a powered hip exoskeleton and its capability to improve locomotion.
Study NCT05949775 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Neoantigen mRNA Personalised Cancer vaccine
Description: Drug: Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab Injection Subcutaneous Injection
Study NCT06494696 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ga-68 PSMA PET/MRI
Description: The participant will undergo a Ga-68 PSMA PET/MRI scan, and then be followed up for 2 years to see if prostate cancer is diagnosed.
Study NCT05543577 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Questionnaire
Study NCT05216679 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Night splints
Description: A night splint is a brace the patient wears on their foot to keep it in a dorsiflexed position while they sleep. It is the first line treatment for plantar fasciitis.
Study NCT05216679 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Triceps Surae Stretching and Flexibility Assessment Device (TESS)
Description: The TESS device is a slant board with a bar added for balance that the participant will stand on in 5 minute intervals throughout the day to stretch their calves, and potentially treat their plantar fasciitis symptoms.
Study NCT04926051 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986172
Description: Specified dose on specified days
Study NCT04926051 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Specified dose on specified days
Study NCT04885803 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Softgel Vitamin D3
Description: 5000IU vitamin D3 taken as single oral softgel once daily for 30 days
Study NCT04885803 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nano Liquid Vitamin D3
Description: 5000IU vitamin D3 taken as liquid oral spray once daily for 30 days
Study NCT04885803 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 25(OH)D Blood Serum Test
Description: A sample of blood is drawn off and processed for 25(OH)D levels at baseline, after 15 days of supplementation, and after 30 days of supplementation
Study NCT04885803 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: 25(OH)D Blood Serum Test
Description: A sample of blood is drawn off and processed for 25(OH)D levels at baseline, after 15 days of supplementation, and after 30 days of supplementation
Study NCT04885803 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: 25(OH)D Blood Serum Test
Description: A sample of blood is drawn off and processed for 25(OH)D levels at baseline, after 15 days of supplementation, and after 30 days of supplementation
Study NCT04885803 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control
Description: Liquid oral spray once daily for 30 days. Solution identical in smell, taste, color, and production process to Nano Liquid D3, but containing no Vitamin D3.
Study NCT05502042 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Case Manager and Peer Support Group
Description: Assignment of a Village health team member to provide support to the family through SMS messages (weeks 1-3) and phone call (week 4), as well as home visits as needed if no contacts are reached. These contacts are intended to provide encouragement and education to participants and families to encourage SAP and peer group attendance. Peer groups will have simple play and support activities, led by the village health team member, to improve the experience of SAP for the participating children.
Study NCT05288218 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Leak-free Bronchoscope Adapter
Description: A novel leak-free bronchoscope adapter will connect to the ventilation circuit in place of a standard adapter.
Study NCT05288218 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Bronchoscope Adapter
Description: Commercially available bronchoscope adapter (Smiths Medical)
Study NCT06054191 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabrafenib + Trametinib
Description: Dabrafenib 150mg BID + Trametinib 2mg QD/（2 cycles）
Study NCT06054191 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capmatinib
Description: Capmatinib 400mg BID/（2 cycles）
Study NCT06156683 — intervention group
Intervention type: OTHER
Intervention: Multiple sclerosis disease modifying drug
Description: There is no treatment allocation. Women with multiple sclerosis with a recorded pregnancy outcome during the inclusion period will be recruited.
Study NCT05725070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 212Pb-NG001
Description: 212Pb-NG001 is a targeted alpha-emitting radiopharmaceutical conjugated to a PSMA targeting peptide.~Patients will receive an initial single 10 MBq dose IV to explore the imaging potential of 212Pb-NG001.
Study NCT05194644 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine physical therapy+ Sensorimotor stimulation
Description: Gustatory, Tactile, Olfactory, Visual and Auditory Stimulation will be applied in sensory stimulation and in motor stimulation strengthening, Proprioceptive neuromuscular facilitation techniques, Balance exercises will be performed
Study NCT05194644 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Routine physical therapy
Description: Active and passive Range of motion exercise of upper and lower limb, Transfer from bed to chair, Sit to stand practice
Study NCT05194644 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine physical therapy
Description: Active and passive Range of motion exercise of upper and lower limb, Transfer from bed to chair, Sit to stand practice
Study NCT06236477 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Personalized Music
Description: Music that is familiar to the child will be played via bluetooth speaker throughout their immediate perioperative care
Study NCT06236477 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: No Music
Description: Participants will receive standard care without music.
Study NCT05472467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: 200mg IV Q3W. Every three weeks is a cycle
Study NCT05472467 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: stereotactic body radiation therapy
Description: stereotactic body radiation therapy for Oligometastases 35Gy/5f(7.0Gy/f,5f per week)
Study NCT05472467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Squamous carcinoma: docetaxel 60 mg/m2, d1 + cisplatin 25 mg/m2, d1-3 or carboplatin AUC=4-6 d1, 21 days for one cycle, up to 4 cycles.~Non-squamous carcinoma: pemetrexed 500 mg/m2, d1 + cisplatin 25 mg/m2, d1-3 or carboplatin AUC=4-6, d1,21 days for one cycle, up to 4 cycles.
Study NCT05353049 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bathing technique based on Basale Stimulation
Description: The relaxing somatic modelling technique will be applied, framed within the concept of Basal Stimulation®. To do this, the user remains seated and the parts of the body that are not being washed at that moment are covered with a towel, favouring the preservation of the user's privacy. The user is lathered up with soft mittens previously moistened with lukewarm water and lathered up. This process shall be carried out starting from the shoulder in a proximal to distal direction on the upper limbs, lower limbs and trunk (taking into account the sagittal anatomical plane) and in a cephalic to caudal direction (taking into account the transverse anatomical plane).~Subsequently, rinsing is carried out following the same guidelines as described above, using moistened soft mittens. Finally, intimate hygiene is performed with a disposable soapy sponge and the soap is rinsed off again with moistened soft terrycloth mittens. Throughout the whole process, the activity is explained to the user.
Study NCT06470113 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: simultaneous cognitive training with transcranial magnetic stimulation
Description: simultaneous cognitive training with transcranial magnetic stimulation can enhance the therapeutic effect and improve brain function non-invasively.
Study NCT06470113 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: simultaneous cognitive training with transcranial magnetic stimulation
Description: simultaneous cognitive training with transcranial magnetic stimulation can enhance the therapeutic effect and improve brain function non-invasively.
Study NCT05182463 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peginterferon Alfa-2B
Description: Different usage of peginterferon Alfa-2B and/or Nucleos(t)ide analogs in arm/group descriptions are depended on the wishes of the patient and the advice of the attending doctor.
Study NCT05182463 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nucleoside Analogs
Description: Nucleos(t)ide analogs refer to one of the first-line drugs, including ETV, TDF and TAF.
Study NCT06219265 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dance Therapy
Description: A single-centre prospective randomised controlled trial will be conducted with a minimum of 48 patients with severe mental disorder (SMD) who will be randomised into two groups, 1 intervention group receiving dance therapy (n=24) and 1 control group receiving no intervention or treatment (n=24).~In addition, there will be an intervention group of healthy people who will receive dance therapy (n=20).~All the tests, will be carried out with patients with SMD and only the EEG for healthy people, in order to determine their baseline state. The dance therapy program will last for 20 sessions over 10 weeks.~The 44 people in the two experimental groups will participate in a 10-week intervention program with 2 sessions per week in which they will work for 1 hour on memory, attention and executive functions through dance and movement, ending with 10 minutes of Mindfulness.~The 24 people in the control group will not receive any type of intervention.
Study NCT05205122 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Combined trabeculotomy-trabeculectomy with mitomycin C
Description: Combined trabeculotomy-trabeculectomy with mitomycin C Will be done in all cases
Study NCT00013221 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Exercise
Study NCT05373407 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: aerobic exercise
Description: participants will perform different dosage of the same intervention, one group will perform moderate intensity and the other will perform low intensity aerobic training
Study NCT05790369 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance training (New ankle machine training)
Description: A six week workout plan, the subjects receive on site or online guidance from professional coaches every two weeks.
Study NCT05790369 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Resistance training (Elastic band training )
Description: A six week workout plan, the subjects receive on site or online guidance from professional coaches every two weeks.
Study NCT05264922 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tisseel Injectable Product
Description: Fibrin glue will provide an inert, biocompatible, viscous substance able to remain within the Rotator Cuff (RC) defect rather than injecting SVF cells in saline.
Study NCT05264922 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tisseel Injectable Product
Description: Fibrin glue will provide an inert, biocompatible, viscous substance able to remain within the Rotator Cuff (RC) defect rather than injecting SVF cells in saline.
Study NCT05264922 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Stromal Vascular Fraction Cells
Description: Stromal Vascular Fraction cells are autologously harvested, processed and reinjected into the affected shoulder.
Study NCT05027555 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multisensory training
Description: Multisensory training included marching on the foam with visual deprivation and treadmill training with visual deprivation
Study NCT05027555 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional training
Description: Conventional training included strengthening, balance training and gait training
Study NCT05234307 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adenosine A2B Receptor Antagonist PBF-1129
Description: Given PO
Study NCT05234307 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Correlative studies
Study NCT05234307 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given IV
Study NCT05166772 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donafenib
Description: 200 mg BID，oral administration will start before the first HAIC treatment.
Study NCT05166772 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: 200 mg，Q3W，Intravenous infusion will performe before HAIC treatment.